Lentz R - Search Results

1

Utilizing left atrial strain to identify patients at risk for atrial fibrillation on ibrutinib.

Singh A, El Hangouche N, McGee K, Gong FF, Lentz R, Feinglass J, Akhter N. Singh A, et al. Among authors: lentz r. Echocardiography. 2021 Jan;38(1):81-88. doi: 10.1111/echo.14946. Epub 2020 Dec 7. Echocardiography. 2021. PMID: 33594858 Free PMC article.

2

Risk factors for the development of atrial fibrillation on ibrutinib treatment.

Lentz R, Feinglass J, Ma S, Akhter N. Lentz R, et al. Leuk Lymphoma. 2019 Jun;60(6):1447-1453. doi: 10.1080/10428194.2018.1533129. Epub 2019 Feb 7. Leuk Lymphoma. 2019. PMID: 30730240

3

The Diagnostic and Prognostic Value of Echocardiographic Strain.

Singh A, Voss WB, Lentz RW, Thomas JD, Akhter N. Singh A, et al. JAMA Cardiol. 2019 Jun 1;4(6):580-588. doi: 10.1001/jamacardio.2019.1152. JAMA Cardiol. 2019. PMID: 31042262 Review.

4

Transarterial Radioembolization in Patients With Unresectable Colorectal Cancer Liver Metastases.

Lentz RW, Messersmith WA. Lentz RW, et al. J Clin Oncol. 2021 Dec 10;39(35):3887-3889. doi: 10.1200/JCO.21.01993. Epub 2021 Sep 20. J Clin Oncol. 2021. PMID: 34541862 No abstract available.

5

Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer.

Leary JB, Hu J, Leal A, Davis SL, Kim S, Lentz R, Friedrich T, Herter W, Messersmith WA, Lieu CH. Leary JB, et al. Among authors: lentz r. JCO Oncol Pract. 2024 Jul 24:OP2400159. doi: 10.1200/OP.24.00159. Online ahead of print. JCO Oncol Pract. 2024. PMID: 39047212

6

Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies.

Lentz R, Benson AB 3rd, Kircher S. Lentz R, et al. J Surg Oncol. 2019 Jul;120(1):85-92. doi: 10.1002/jso.25374. Epub 2019 Jan 16. J Surg Oncol. 2019. PMID: 30650186 Review.

7

Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?

Lentz RW, Colton MD, Mitra SS, Messersmith WA. Lentz RW, et al. Mol Cancer Ther. 2021 Jun;20(6):961-974. doi: 10.1158/1535-7163.MCT-21-0041. Epub 2021 Apr 13. Mol Cancer Ther. 2021. PMID: 33850005 Free PMC article. Review.

8

A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer.

Lentz RW, Friedrich TJ, Blatchford PJ, Jordan KR, Pitts TM, Robinson HR, Davis SL, Kim SS, Leal AD, Lee MR, Waring MRN, Martin AC, Dominguez ATA, Bagby SM, Hartman SJ, Eckhardt SG, Messersmith WA, Lieu CH. Lentz RW, et al. Clin Cancer Res. 2024 Sep 3;30(17):3768-3778. doi: 10.1158/1078-0432.CCR-24-0090. Clin Cancer Res. 2024. PMID: 38869830 Free PMC article. Clinical Trial.

9

Early Assessment of Molecular Progression and Response by Whole-genome Circulating Tumor DNA in Advanced Solid Tumors.

Davis AA, Iams WT, Chan D, Oh MS, Lentz RW, Peterman N, Robertson A, Shah A, Srivas R, Wilson TJ, Lambert NJ, George PS, Wong B, Wood HW, Close JC, Tezcan A, Nesmith K, Tezcan H, Chae YK. Davis AA, et al. Among authors: lentz rw. Mol Cancer Ther. 2020 Jul;19(7):1486-1496. doi: 10.1158/1535-7163.MCT-19-1060. Epub 2020 May 5. Mol Cancer Ther. 2020. PMID: 32371589 Free PMC article.

10

Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment.

Amo-Aparicio J, Dominguez A, Atif SM, Dinarello A, Azam T, Alula KM, Piper M, Lieu CH, Lentz RW, Leal AD, Bagby SM, Messersmith WA, Karam SD, Dinarello CA, Pitts TM, Marchetti C. Amo-Aparicio J, et al. Cancer Res Commun. 2023 Sep 20;3(9):1899-1911. doi: 10.1158/2767-9764.CRC-23-0065. Cancer Res Commun. 2023. PMID: 37772994 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page